Please login to the form below

Not currently logged in
Email:
Password:

Youssef Bennani to chair Domain Therapeutics

He is VP R&D at Vertex
Youssef Bennani Domain

Domain Therapeutics has named Youssef Bennani as chairman of the company's board, taking over from Sam Eletr.

Bennani currently serves as site head and VP of R&D at Vertex Pharmaceuticals' site in Laval, Quebec. Prior to this, he spent seven years as VP of drug innovation at Vertex
.


“Dr Bennani joins us at a time when we intend to strengthen our role as a pharma industry partner and expand our internal pipeline,” said Pascal Neuville, board director and CEO of Domain.

This pipeline includes new drug candidates targeting G protein-coupled receptors. Domain has several partnerships involving these products, including one with Merck Serono in Parkinson's disease.

2nd June 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...